![Pfizer / Gabapentin / Off-label use / Pharmaceutical industry / Food and Drug Administration / Medical prescription / Prescription medication / PharmedOut / Parke-Davis / Pharmacology / Pharmaceutical sciences / Medicine Pfizer / Gabapentin / Off-label use / Pharmaceutical industry / Food and Drug Administration / Medical prescription / Prescription medication / PharmedOut / Parke-Davis / Pharmacology / Pharmaceutical sciences / Medicine](https://www.pdfsearch.io/img/221530bd38fdc2282a361b7e6ba9fd4b.jpg)
| Document Date: 2011-07-20 17:26:04 Open Document File Size: 30,17 KBShare Result on Facebook
Company Pfizer Inc. / Warner-Lambert / / Currency USD / / Event FDA Phase / / IndustryTerm pharmaceutical company resolving allegations / corrective advertising program / / MedicalCondition seizure disorders / epileptic seizures / / Organization Federal Drug Administration / office of the Attorney General Paul G. Summers NEWS RELEASE FOR IMMEDIATE RELEASE / / Person Paul G. Summers / Sharon Curtis-Flair / / / Position Drug Company Agreement Attorney General / Governor / Attorney General / Attorneys General / / Product Neurontin / Federal Drug / / ProvinceOrState Texas / Vermont / Ohio / Oregon / Florida / North Carolina / California / New York / / URL www.publichealthtrust.org.www.naag.gov / /
SocialTag |